Basit öğe kaydını göster

Differential effects of clozapine and risperidone on facial emotion recognition ability in patients with treatment-resistant schizophrenia

dc.contributor.authorBas, Tuba Ocek
dc.contributor.authorGultekin, Gozde
dc.contributor.authorKalelioglu, Tevfik
dc.contributor.authorYuksek, Erhan
dc.contributor.authorDuran, Alaattin
dc.contributor.authorBas, Alper
dc.date.accessioned2021-03-06T09:27:02Z
dc.date.available2021-03-06T09:27:02Z
dc.date.issued2017
dc.identifier.citationGultekin G., Yuksek E., Kalelioglu T., Bas A., Bas T. O. , Duran A., "Differential effects of clozapine and risperidone on facial emotion recognition ability in patients with treatment-resistant schizophrenia", PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, cilt.27, ss.19-23, 2017
dc.identifier.issn2475-0573
dc.identifier.otherav_e59ccfdb-76ff-4d1f-847b-6f2643dc8eda
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/151043
dc.identifier.urihttps://doi.org/10.1080/24750573.2017.1293242
dc.description.abstractObjective: Clozapine and risperidone are used for treatment-resistant schizophrenia and known to improve the positive and negative symptoms. However, there are some conflicts about effects on social cognition, which is measured with facial emotion recognition ability. The impairments in facial emotion recognition ability have frequently been in different stages of the illness and might have negative influences on psychosocial functioning. In the present study, we aimed to examine clozapine and risperidone effects recognizing facial emotions in patient with treatment-resistant schizophrenia.
dc.language.isoeng
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectSağlık Bilimleri
dc.subjectTemel Eczacılık Bilimleri
dc.subjectEczacılık
dc.subjectKlinik Tıp (MED)
dc.subjectPsikiyatri
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.titleDifferential effects of clozapine and risperidone on facial emotion recognition ability in patients with treatment-resistant schizophrenia
dc.typeMakale
dc.relation.journalPSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume27
dc.identifier.issue1
dc.identifier.startpage19
dc.identifier.endpage23
dc.contributor.firstauthorID239423


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster